Panel of serum biomarkers for the diagnosis of lung cancer.
about
"Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary diseaseUpdate in lung cancer 2007Collagen XXIII: a potential biomarker for the detection of primary and recurrent non-small cell lung cancerEpidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesA Highly Efficient Gene Expression Programming (GEP) Model for Auxiliary Diagnosis of Small Cell Lung CancerUnlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancerNanostructured optical photonic crystal biosensor for HIV viral load measurement.A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screeningAdvances in proteomic strategies toward the early detection of lung cancerGene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease.Imaging and 'omic' methods for the molecular diagnosis of cancer.Diagnostic characteristics of a serum biomarker in patients with positron emission tomography scans.Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry.Identification of lung cancer with high sensitivity and specificity by blood testing.Improving Detection Accuracy of Lung Cancer Serum Proteomic Profiling via Two-Stage Training Process.Validation of a blood protein signature for non-small cell lung cancerProteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometryIdentification of candidate biomarkers for early detection of human lung squamous cell cancer by quantitative proteomics.The potential role of ORM2 in the development of colorectal cancer.National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654): design, intent, and availability of specSerum unsaturated free Fatty acids: potential biomarkers for early detection and disease progression monitoring of non-small cell lung cancer.Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC).Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.Integrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancerMultiplexed volumetric bar-chart chip for point-of-care diagnosticsThe value of surface enhanced laser desorption/ionization-time of flight mass spectrometry at the diagnosis of non-small cell lung cancer: a systematic review.An empirical assessment of validation practices for molecular classifiersSerum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer.Insulin-like growth factor binding protein-2 level is increased in blood of lung cancer patients and associated with poor survival.Serum peptidomic profiling identifies a minimal residual disease detection and prognostic biomarker for patients with acute leukemia.Urinary protein biomarkers in the early detection of lung cancer.Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.Serum peptide pattern that differentially diagnoses hepatitis B virus-related hepatocellular carcinoma from liver cirrhosis.Lung cancer proteomics: recent advances in biomarker discoveryCarbonic anhydrase 1 is a promising biomarker for early detection of non-small cell lung cancer.Oncoproteomics: Trials and tribulations.High sensitivity automated multiplexed immunoassays using photonic crystal enhanced fluorescence microfluidic systemSerum biomarker panels for the diagnosis of gastric adenocarcinoma.Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned mediumDiagnostic value of CYFRA 21-1 and CEA for predicting lymph node metastasis in operable lung cancer
P2860
Q21131903-62969DA7-200E-4971-AF49-16A755EC772FQ22241904-D8783E3F-B7A8-4C1C-92BB-2A2052554997Q24600990-ED8A0A1C-CA5A-40E9-B0E1-F864A3A975EBQ27023830-8230CB8B-4A32-46EC-93A1-CAC5377669CAQ28547421-6E4E3786-7FC3-40CA-A410-C60014A9550EQ28744369-D59F679D-1318-4032-8592-F28D0CE7DB85Q30442145-C1EBC265-ED7D-475D-8493-6078CD14DA8CQ30511822-5D09F3C8-17E7-4AAA-A2F0-EA5227246493Q31008766-90DE5B42-209C-49D6-9A59-DFFEF8986864Q33559278-9E7AC4F3-E666-4811-852E-52FEFCA20AC7Q33577268-2AAAB781-00B8-4302-82CF-6BA3D5CC3138Q33584655-3AFDEFB4-4A08-467D-88DD-DC22947794A3Q33631062-B31DA83F-EADF-41F9-BBE3-E207610A78B8Q33705551-2F29C0D1-4959-47E6-AC82-4ABF25CF4D4DQ33874499-D49E0CE2-5599-424A-800A-999575604C43Q34008245-8039B0C2-38B0-4E90-937B-9C353AC71A16Q34077576-167E6F1A-D540-4724-81D0-AF4CC27B5504Q34148738-1EB93520-4F1D-4447-A502-3F212D65879BQ34171477-3AF55CC1-8C53-4B3D-8ABF-9AF1F1DBB8D7Q34237215-F3C4B7A9-99A5-4AA7-837F-22544669F635Q34241084-F0164544-7702-4A4F-AC8D-315243B2E27AQ34281288-0B6BAB1F-C5BB-477B-A1F3-6B6F40910078Q34350615-A6FBB182-B39C-4215-9306-52E8767470EFQ34532251-3558CF40-E66C-4001-B987-D655AFEB39E9Q34700249-E108F996-7C8A-4D75-AD8E-0A50D0803E97Q34829225-2ED33B26-14BF-45D6-A7DA-468774E97CF9Q34933977-5B5102B6-6F57-4A48-B575-2A8F1B2C93AFQ34998455-95E6DA14-A47A-4583-AC81-BECE1B064549Q34999407-FA6450F0-028F-475B-9130-8059FC89731BQ35030141-FB5A9BD1-60FF-4C09-8D23-A7F430909272Q35044516-55DDF97D-B19F-4502-A3B1-59E3D774AFF2Q35104929-C7AD0EA7-BD43-479F-B9F8-FC34954F147AQ35115406-ED8E27F5-7AC3-44B7-9B7C-3129CC8236AEQ35389059-FE890B80-C7D0-4B00-9098-6D904D588637Q35732686-5E8170C3-8B9D-438E-9DF0-522766A94DCBQ35827653-F853339C-EABE-43A9-8E85-AB74158F20FFQ35875983-AEBEC35F-4DE4-4A97-8738-7FA35E9149DAQ35879848-8FE32300-81E0-4D72-8F48-60AAD75FDC24Q35957217-CE543315-CCD4-4FFC-9993-074FC461C9ADQ35959035-83E8158C-B38F-4A6C-B7BC-487E96476038
P2860
Panel of serum biomarkers for the diagnosis of lung cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Panel of serum biomarkers for the diagnosis of lung cancer.
@en
Panel of serum biomarkers for the diagnosis of lung cancer.
@nl
type
label
Panel of serum biomarkers for the diagnosis of lung cancer.
@en
Panel of serum biomarkers for the diagnosis of lung cancer.
@nl
prefLabel
Panel of serum biomarkers for the diagnosis of lung cancer.
@en
Panel of serum biomarkers for the diagnosis of lung cancer.
@nl
P2093
P356
P1476
Panel of serum biomarkers for the diagnosis of lung cancer.
@en
P2093
Edward F Patz
Elizabeth B Gottlin
Irina Kusmartseva
James E Herndon
Michael J Campa
Xiang Rong Guan
P304
P356
10.1200/JCO.2007.13.5392
P407
P577
2007-12-01T00:00:00Z